LifeArc (@lifearc1) 's Twitter Profile
LifeArc

@lifearc1

Medical research non-profit transforming promising life science ideas into medical breakthroughs that change patients’ lives.

ID: 21754354

linkhttp://www.lifearc.org calendar_today24-02-2009 13:43:34

3,3K Tweet

7,7K Followers

3,3K Following

LifeArc (@lifearc1) 's Twitter Profile Photo

Partner with us on antibody discovery to accelerate your research, reduce risks, and ensure high-quality outcomes. Interested in collaborating? Get in touch to discuss partnering with us! lifearc.org/what-we-do/sci…

Partner with us on antibody discovery to accelerate your research, reduce risks, and ensure high-quality outcomes.

Interested in collaborating? Get in touch to discuss partnering with us! lifearc.org/what-we-do/sci…
LifeArc (@lifearc1) 's Twitter Profile Photo

What's it like to work at LifeArc? • Purpose-driven roles • Inclusive, supportive culture • Career development • Flexibility & wellbeing Explore more: lifearc.org/careers/workin…

What's it like to work at LifeArc?

• Purpose-driven roles
• Inclusive, supportive culture
• Career development
• Flexibility & wellbeing

Explore more: lifearc.org/careers/workin…
LifeArc (@lifearc1) 's Twitter Profile Photo

🌍 Today on #WorldBronchiectasisDay, join us in raising awareness about this chronic lung condition affecting over 200,000 people in the UK. Learn more about the condition through Charlotte's story. #BronchiectasisAwareness

LifeArc (@lifearc1) 's Twitter Profile Photo

A new NHS service, MinderCare, which uses smart devices to help people with dementia live well at home for longer, has just launched. We are proud to have provided funding and support to this service through our partnership with UK Dementia Research Institute. Read more: lifearc.org/2025/innovativ…

A new NHS service, MinderCare, which uses smart devices to help people with dementia live well at home for longer, has just launched.

We are proud to have provided funding and support to this service through our partnership with <a href="/UKDRI/">UK Dementia Research Institute</a>.

Read more: lifearc.org/2025/innovativ…
LifeArc (@lifearc1) 's Twitter Profile Photo

This week, we welcomed Varaidzo Joy Mukwekwe to our data science team. She joins us via the Health Data Research UK (HDR UK) Health Data Science Black Internship Programme, and will be supporting a tuberculosis study for the next 10 weeks. Welcome, Varaidzo Joyline Mukwekwe!

This week, we welcomed Varaidzo Joy Mukwekwe to our data science team. She joins us via the <a href="/HDR_UK/">Health Data Research UK (HDR UK)</a>  Health Data Science Black Internship Programme, and will be supporting a tuberculosis study for the next 10 weeks.

Welcome, <a href="/VaraidzoJoy17/">Varaidzo Joyline Mukwekwe</a>!
LifeArc (@lifearc1) 's Twitter Profile Photo

This week, we held our second Neurodegeneration Strategic Advisory Workshop to discuss how we can drive meaningful impact in rare dementias, and help shape a future strategy for accelerating the translation of therapies to the clinic. Thanks to all attendees for joining us!

This week, we held our second Neurodegeneration Strategic Advisory Workshop to discuss how we can drive meaningful impact in rare dementias, and help shape a future strategy for accelerating the translation of therapies to the clinic. Thanks to all attendees for joining us!
LifeArc (@lifearc1) 's Twitter Profile Photo

With UK Dementia Research Institute, we're funding a first-in-class gene therapy targeting a root cause of motor neuron disease: gene errors caused by TDP-43 dysfunction. This new treatment aims to correct faulty gene messages and deliver long-lasting treatment in a single dose.

With <a href="/UKDRI/">UK Dementia Research Institute</a>, we're funding a first-in-class gene therapy targeting a root cause of motor neuron disease: gene errors caused by TDP-43 dysfunction.

This new treatment aims to correct faulty gene messages and deliver long-lasting treatment in a single dose.
LifeArc (@lifearc1) 's Twitter Profile Photo

We're calling on government, regulators, industry, academia, the NHS and patient groups to act together and #ChangeTheRareFuture for people living with rare conditions in the UK. Read the report here - lifearc.org/rd-report/ Genetic Alliance UK

We're calling on government, regulators, industry, academia, the NHS and patient groups to act together and #ChangeTheRareFuture for people living with rare conditions in the UK. Read the report here - lifearc.org/rd-report/

<a href="/GeneticAll_UK/">Genetic Alliance UK</a>
LifeArc (@lifearc1) 's Twitter Profile Photo

Our Rare Disease Chair, Amit Nathwani, shares why it's so important that we #ChangeTheRareFuture for the nearly 3.5 million people with rare diseases in the UK at our report launch in Westminster. Genetic Alliance UK

Our Rare Disease Chair, Amit Nathwani, shares why it's so important that we #ChangeTheRareFuture for the nearly 3.5 million people with rare diseases in the UK at our report launch in Westminster.

<a href="/GeneticAll_UK/">Genetic Alliance UK</a>
LifeArc (@lifearc1) 's Twitter Profile Photo

"This Government remains committed to improving the lives of people with rare diseases… This is not something that [we] can do alone. We will do it in partnership with experts and with people with rare diseases and their families." Ashley Dalton MP #ChangeTheRareFuture

"This Government remains committed to improving the lives of people with rare diseases…

This is not something that [we] can do alone. We will do it in partnership with experts and with people with rare diseases and their families." <a href="/AshleyDalton_MP/">Ashley Dalton MP</a>  #ChangeTheRareFuture
LifeArc (@lifearc1) 's Twitter Profile Photo

"The future of medicine – for all of us – is more personalised, more precise, and more patient-led... We must act today to work together and to transform the system for the millions of people living with rare diseases." -Sam Barrell, LifeArc CEO #ChangeTheRareFuture

"The future of medicine – for all of us – is more personalised, more precise, and more patient-led... We must act today to work together and to transform the system for the millions of people living with rare diseases." -Sam Barrell, LifeArc CEO
#ChangeTheRareFuture
Genetic Alliance UK (@geneticall_uk) 's Twitter Profile Photo

More rare disease R&D in the UK means faster diagnoses, better treatments and hope for millions living with rare conditions. We are proud to collaborate with @LifeArc and task force members on this, read recommendations here: t.ly/8lqIH Let’s #ChangeTheRareFuture

More rare disease R&amp;D in the UK means faster diagnoses, better treatments and hope for millions living with rare conditions. We are proud to collaborate with @LifeArc and task force members on this, read recommendations here: t.ly/8lqIH

Let’s #ChangeTheRareFuture
LifeArc (@lifearc1) 's Twitter Profile Photo

On Monday, our new report with Genetic Alliance UK launched. Here, our Chair of Rare Disease, Amit Nathwani, talks about why it's so important that we, as a nation, work together to #ChangeTheRareFuture. Read the report: lifearc.org/rd-report/

LifeArc (@lifearc1) 's Twitter Profile Photo

These human medulloblastoma (DAOY) cells have been probed for IL6 RNA during motor neuron disease assay development, along with the nuclear stain Hoechst. This image is courtesy of our team working on our induced pluripotent stem cell (iPSC) platform. Photo: Dhaluni

These human medulloblastoma (DAOY) cells have been probed for IL6 RNA during motor neuron disease assay development, along with the nuclear stain Hoechst.

This image is courtesy of our team working on our induced pluripotent stem cell (iPSC) platform.

Photo: <a href="/dhaluni_k/">Dhaluni</a>
LifeArc (@lifearc1) 's Twitter Profile Photo

Last week, we hosted over 100 policy makers, charity, industry and academic partners, and patient experts for breakfast to talk about how we can #ChangeTheRareFuture in the UK and change millions of lives. Read our latest report with Genetic Alliance UK here - lifearc.org/rd-report/

Last week, we hosted over 100 policy makers, charity, industry and academic partners, and patient experts for breakfast to talk about how we can #ChangeTheRareFuture in the UK and change millions of lives. Read our latest report with <a href="/GeneticAll_UK/">Genetic Alliance UK</a> here - lifearc.org/rd-report/
LifeArc (@lifearc1) 's Twitter Profile Photo

To drive meaningful progress in MND research, we must listen to those it impacts most. Over the past year, we've captured lived perspectives to better understand needs. Some of the findings are below. You can read our first MND Insights Report 👉 lifearc.org/wp-content/upl…

To drive meaningful progress in MND research, we must listen to those it impacts most. Over the past year, we've captured lived perspectives to better understand needs. Some of the findings are below. You can read our first MND Insights Report 👉 lifearc.org/wp-content/upl…
LifeArc (@lifearc1) 's Twitter Profile Photo

Bronchiectasis affects 200,000 people in the UK alone. Ongoing inflammation causes airway damage – making it an essential target for new therapies. That's where AIRNET comes. @JamesDChalmers University of Dundee #WBC2025

Bronchiectasis affects 200,000 people in the UK alone. Ongoing inflammation causes airway damage – making it an essential target for new therapies.

That's where AIRNET comes.

@JamesDChalmers <a href="/dundeeuni/">University of Dundee</a> #WBC2025
LifeArc (@lifearc1) 's Twitter Profile Photo

New research, published in The Lancet Neurology last night and partly funded by our Pathfinder Award, brings long-awaited answers to families who have lived with years of uncertainty - lifearc.org/2025/lifearc-p…

New research, published in <a href="/TheLancet/">The Lancet</a> Neurology last night and partly funded by our Pathfinder Award, brings long-awaited answers to families who have lived with years of uncertainty - lifearc.org/2025/lifearc-p…